Literature DB >> 30706633

Coordination Chemistry of Organoruthenium Compounds with Benzoylthiourea Ligands and their Biological Properties.

Shahida Parveen1,2, Kelvin K H Tong1, Muhammad Khawar Rauf3, Mario Kubanik1, Muhammad Ashraf Shaheen2, Tilo Söhnel1, Stephen M F Jamieson4, Muhammad Hanif1, Christian G Hartinger1.   

Abstract

Benzoylthiourea derivatives feature several donor atoms capable of coordinating to metal centers. We report here a series of Ru(η6 -p-cymene) complexes employing benzoylthiourea derivatives as ligands. Such ligands often coordinate to metal centers through their S and O donor atoms. We isolated complexes where the ligands were mono- or bidentately coordinated to Ru involving the S donor atom and surprisingly in bidentate coordination mode a deprotonated thiourea nitrogen resulting in a 4-membered ring structure around the metal center. DFT calculations were used to explain the differences in coordination behavior. These were complemented by stability studies and biological investigations of the compounds as anticancer agents. Several of the synthesized derivatives exhibited significant cell growth inhibitory activity, with the complexes featuring bidentate ligands being more potent than their monodentate counterparts. This can be explained by the higher stability of the former under the conditions employed in cell culture assays.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  anticancer activity; benzoylthiourea; bioorganometallics; ruthenium; thioamide

Mesh:

Substances:

Year:  2019        PMID: 30706633     DOI: 10.1002/asia.201801798

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  1 in total

1.  Novel adamantyl clubbed iminothiazolidinones as promising elastase inhibitors: design, synthesis, molecular docking, ADMET and DFT studies.

Authors:  Atteeque Ahmed; Aamer Saeed; Syeda Abida Ejaz; Mubashir Aziz; Muhammad Zaffar Hashmi; Pervaiz Ali Channar; Qamar Abbas; Hussain Raza; Zahid Shafiq; Hesham R El-Seedi
Journal:  RSC Adv       Date:  2022-04-19       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.